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Abstract 29 
 30 
Combining antimicrobials to reduce microbial growth and to combat the potential impact of 31 
antimicrobial resistance is an important subject both in foods and in pharmaceutics. 32 
Modelling of combined treatments designed to reduce or eliminate microbial contamination 33 
in foods (microbiological predictive modelling) has become commonplace. Two main 34 
reference models are used to analyse mixtures: the Bliss Independence and the Loewe 35 
reference models (LRM).  36 
 37 
By using optical density to analyse the growth of Aeromonas hydrophila, Cronobacter 38 
sakazakii and Escherichia coli, in combined NaCl/NaCl (a mock combination experiment) 39 
and combined NaCl/KCl experiments, previous models for combined antimicrobials in foods, 40 
based on the Bliss approach, were shown to be inconsistent and that models based on the 41 
LRM more applicable.  42 
 43 
The LRM was shown, however, to be valid only in the specific cases where the 44 
concentration exponents of all components in a mixture were identical. This is assured for a 45 
mock combination experiment but not for a true mixture. This, essentially, invalidates the 46 
LRM as a general reference model. A new model, based on the LRM but allowing for mixed 47 
exponents, was used to analyse the combined inhibition data, and concluded that the 48 
NaCl/KCl system gave the additive effect expected from literature studies. This study 49 
suggests the need to revise current models used to analyse combined effects.  50 
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1 Introduction 51 
Combining appropriate antimicrobials whether in foods or in pharmaceutics is a strategy to 52 
reduce the total loading of the combined preservatives or drugs, potentially reduce drug 53 
toxicity, increase the spectral range of the mixture beyond that of any one adjunct, and of 54 
increasing importance - to help combat the emergence of antimicrobial resistance (CDC 55 
2013, Krueger et al., 2014). In foods the combination of several preservation methods can 56 
be used to reduce organoleptically deleterious effects of using a single or a few factors to 57 
preserve food products. This approach, known as combined hurdle technology, although 58 
distinct from combined antimicrobials in pharmaceutics has the same goal – to reduce a 59 
negative effect through combination (Leistner and Gorris 1995). 60 
 Much effort has gone into developing and advancing mathematical models for the 61 
prediction of growth of food borne pathogens in foods preserved by combinations of hurdles 62 
such as thermal processing, holding temperature, acidity, water activity, multiple 63 
preservatives, initial inoculum size, the shelf-life and the impact of transportation.  These 64 
models have become an integral part of modern-day food microbiology, e.g. in HACCP and 65 
microbiological risk analysis (Dominguez and Schaffner 2009; Membré and Lambert 2008; 66 
Nychas et al., 2008).  67 
 One particular approach to modelling microbial growth in foods is the Gamma 68 
approach in which individual effects are combined multiplicatively and is based on Leistner’s 69 
Hurdle idea (Zwietering et al., 1992). For each inhibitory effect a growth factor is calculated 70 
based on the ratio of the applied level to the optimum level for microbial growth. 71 
Multiplication of these gamma factors () gives the overall growth factor which alters, for 72 
example, the growth rate from its optimum value. 73 
 74 
𝛾𝑡𝑜𝑡𝑎𝑙 =
𝜇
𝜇𝑜𝑝𝑡
= 𝛾(𝑇). 𝛾(𝑝𝐻). 𝛾(𝐴𝑤). 𝛾(𝑃𝑟𝑒𝑠) 75 
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Eqn. 1. The Gamma model combining the gamma factors () for temperature (T), pH, water activity 76 
(Aw) and applied preservatives (Pres) to predict the microbial growth rate (), relative to the optimal 77 
growth rate(opt).  78 
 As presented the Gamma hypothesis collates the applied factors as independent 79 
entities. This is an oversimplification, and Eqn.1 can only be considered a first 80 
approximation. The reason being that temperature affects pH, water activity and also the 81 
efficacy of preservatives – especially those that have partition abilities and furthermore weak 82 
acid preservatives are affected by temperature, pH and water activity. Some of these effects 83 
can be incorporated into a modelling scheme (e.g. pH and weak acids through the use of the 84 
pKa), whilst others have to be modelled on a case-by case basis (e.g., Arroyo-Lopez et al., 85 
2012; Coroller et al., 2012; Lambert and Bidlas 2007).  Combinations of hurdles which 86 
appear to give a greater effect than that described by the Gamma model may claim to show 87 
synergy: the magnitude of the synergy is claimed relative to the expected effect (Eqn. 1) 88 
(Augustin and Carlier 2000a, 2000b). 89 
 Previously, the effect of individual preservatives against spoilage and pathogenic 90 
bacteria had been successfully modelled using a monotonic exponential decay function 91 
(Lambert and Pearson 2000). Later studies of inhibition using multiple inhibitory factors 92 
assumed that the gamma factor for an individual preservative could be expanded for 93 
combinations, giving a model, based upon the Gamma hypothesis, which simply combined 94 
the contribution from each component (Eqn 2). 95 
  96 
𝛾(𝑃𝑟𝑒𝑠)𝑡𝑜𝑡𝑎𝑙 =  𝛾(𝑃𝑟𝑒𝑠1). 𝛾(𝑃𝑟𝑒𝑠2). 𝛾(𝑃𝑟𝑒𝑠3)… 97 
Eqn. 2.  98 
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For example the combined effect of pH, acetic and propionic acids against Aeromonas 99 
hydrophila was given as  100 
 101 
𝛾(𝑃𝑟𝑒𝑠) = 𝑒𝑥𝑝 {− [(
10−𝑝𝐻
𝑃1
)
𝑚1
+ (
𝐴𝑐𝑒𝑡𝑖𝑐
𝑃2
)
𝑚2
+ (
𝑃𝑟𝑜𝑝𝑖𝑜𝑛𝑖𝑐
𝑃3
)
𝑚3
]} 102 
Eqn. 3. A Gamma model used for the prediction of the effect of combined acetic and propionic acids 103 
at a given pH. Pi are concentration parameters and mi are the concentration exponents. 104 
This model gave a very good fit to the observed data and gave us confidence in describing 105 
the combination as additive (in the sense of independent action (Lambert and Bidlas 2007)). 106 
 Within pharmaceutics the basis of much of the literature on drug combinations is 107 
based on one of two reference models, the Bliss independence model, of which the Gamma 108 
model (Eqn.1) is an example, and the Loewe reference model (LRM, Eqn.4) (Chou 2006; 109 
Greco et al., 1995). 110 
∑
𝑥𝑖
𝑋𝑖
= 1
𝑛
𝑖=1
 112 
 111 
Eqn. 4 The Loewe Reference Model (LRM): An n-component mixture has a given effect, which is 113 
elicited individually at concentrations Xi; in the mixture the fractional amount of each component, x i /Xi, 114 
sums to give the same effect. 115 
 116 
 Equation 4 is the equation of a (n-1)-dimensional hyperplane and it defines the 117 
expected additive behaviour of a mixture and “deviation from expectation unequivocally 118 
indicates an interaction and its type” (Berenbaum 1985). A mixture, which satisfies the LRM, 119 
is labelled as Loewe additive; if the combination achieved the effect, but with a value less 120 
than 1 then the mixture is labelled as synergistic, and antagonistic if it is greater than 1. For 121 
binary combinations a linear line (an isobole) joining X1 and X2 indicates additive behaviour, 122 
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a concave line describes the presence of synergy and a convex one the presence of 123 
antagonism (Berenbaum 1978).  124 
 One of the most used methods for analysing synergy in pharmaceutical combinations 125 
is that of Chou and Talalay (CT), (Chou 2006). This uses the Hill model to describe the 126 
action of individual drugs (Goutelle et al., 2008). The CT method, however, does not model 127 
an overall effect, but calculates a measure of the interaction - the Combination Index (CI) for 128 
each observed combination of drugs, based on the LRM. The CI is therefore identical to the 129 
sum of the fractional inhibitory concentrations (FIC) much used in the analysis of 130 
antimicrobial combinations (Hall et al., 1983). 131 
 Herein we present a more general model for combined antimicrobials, through a 132 
revision of the LRM, which gives a more consistent framework for producing more complex 133 
models – both in foods and with pharmaceutics.  To achieve this we have examined the 134 
effect of NaCl and/or KCl on the growth of 3 organisms: Aeromonas hydrophila, Cronobacter 135 
sakazakii and Escherichia coli.  136 
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2 Methods 137 
2.1 MICROBES AND EXPERIMENTAL SET UP 138 
Cronobacter sakazakii  (FSM263, isolated from a factory producing infant formula), 139 
Aeromonas hydrophila (ATCC 7966) or Escherichia coli (ATCC 11229) were grown 140 
overnight in a flask containing 80 ml tryptone soya broth (TSB; Oxoid CM 129) shaking at 141 
30oC. The cells were harvested, centrifuged to a pellet, washed and re-suspended in 142 
peptone water. A standard inoculum was produced by diluting the culture to an optical 143 
density (OD) of 0.5 at 600nm. This standardized culture was then further diluted to produce 144 
the starting inoculum of approximately 1x105 cfu ml-1. 145 
 146 
All analyses were performed in Bioscreen Microbiological Analysers (Bioscreens), 147 
Labsystems Helsinki, Finland.  148 
 149 
The analysis of NaCl or KCl on the organisms used twenty linear dilutions of a stock solution 150 
(10% (wt/vol) to 0.5% in 0.5% intervals) of sodium chloride or potassium chloride (Sigma 151 
Aldrich, UK) prepared in TSB. Each dilution (200l) was placed in a column of the Bioscreen 152 
plate, giving 10 replicates per concentration (2 plates per experiment). For each protocol 153 
diluted standard inoculum was added (50l) to all wells except the negative control wells 154 
(+50 l of TSB). Plates were incubated for 7 days at 30oC taking OD measurements 155 
automatically every ten minutes at 600nm. 156 
 157 
For combined NaCl/NaCl and NaCl/KCl experiments a 20 x 20 grid over 4 Bioscreen plates 158 
was used. Linear dilutions of each test antimicrobial were made (10% (wt/vol) to 0.5% in 159 
0.5% intervals) and each dilution (100l) placed in either a column or a row of the Bioscreen 160 
plates. Standard inoculum (100l) was then added to each well. Plates were incubated in 161 
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two Bioscreens for 7 days at 30oC taking OD measurements automatically every ten minutes 162 
at 600nm. 163 
 164 
The time to detection (TTD) was defined as the time to produce an OD = 0.2, the time to 165 
detection was obtained through polynomial interpolation and has an accuracy of ± 1min. 166 
 167 
2.2 THEORY AND MODEL DEVELOPMENT 168 
For a single bioactive, with a monotonic response to concentration and which follows the 169 
Lambert-Pearson model (Lambert and Pearson 2000, LPM), two parameters are required to 170 
describe its action (Eqn. 5).  If a system of combined hurdles is purely additive, then 171 
observations should be predictable using the parameters derived from the fitting of the LPM 172 
to each of the individual bioactives used.  173 
 174 















m
P
X
eff exp  175 
Eqn. 5. Where eff is the effect measured, P is the concentration at the inflexion point and m is the 176 
concentration exponent and X is the concentration of the bioactive substance.  177 
 178 
2.2.1 Mock experiment 179 
A standard method used in the development of combination models is the combination of 180 
self with self, known as the mock experiment; this cannot be synergistic only additive. 181 
Consider an antimicrobial compound a, and another compound b, which are given to the 182 
experimenter each of which follows the LPM. Unknown to the experimenter, compound b is 183 
in fact compound a but deviously labelled as b. Analysis of each reveals identical P and m 184 
parameters; and for any given effect a/2 +b/2 gives the effect of a by itself (or b) (labelled as 185 
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A or B). For any given effect if a/A is plotted against b/B then a linear line connects the 186 
points – a linear isobole – since the ratios of the fractional effects must sum to 1. Therefore 187 
since in this (mock) experiment there can be no synergy a linear isobole is assumed to be 188 
equivalent to an additive effect between the components in a mixture.  189 
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Eqn. 6. In the mock experiment  a = b 191 
2.2.2 Identical Exponents 192 
Consider two distinct antimicrobials x1 and x2, both of which can be modelled by the LPM, 193 
and in which the exponents, m, are equivalent, then a model describing the combined effect 194 
is given by 195 















m
P
x
P
x
eff
2
2
1
1exp  196 
Eqn. 7 197 
The combined model cannot be 198 
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Eqn. 8 200 
as this violates the requirement of the mock experiment unless m = 1.  201 
 202 
2.2.3 Extended LPM Model and an adaptation of the LRM 203 
Consider again two bioactives x1 and x2, both of which can be modelled by the LPM, and in 204 
which their exponents are not equivalent. Eqn. (7) is no longer applicable as the equation 205 
cannot produce the individual exponents. The format of Eqn. (7) does however provide a 206 
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clue as to how to proceed along a different line of investigation. The expansion of the values 207 
within the bracket follows a standard binomial expansion when m is an integer and the non-208 
integral (Newtonian) expansion when m is real.  209 
 210 
A particular solution to the problem of mixed exponents for a binary system is given by Eqn. 211 
9.  212 
 213 
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Eqn. 9 215 
If m1= m2  then the model reduces to Eqn.7; if x2 tends to zero then the LPM for x1 is 216 
obtained and vice-versa. For a system of n bioactives this model expands to give 217 
 nmEffCeff  exp  218 
where 219 
𝐸𝑓𝑓𝐶 =  
{
 
 
 
 
(
 
 
 
(
 
 
…
(
 ((𝑥1
𝑚1
𝑚2 + 𝑥2)
𝑚2
𝑚3
+ 𝑥3)
𝑚3
𝑚4
+ 𝑥4
)
 
𝑚4
𝑚5
+⋯𝑥𝑛−1
)
 
 
𝑚𝑛−1
𝑚𝑛
+ 𝑥𝑛
)
 
 
 
}
 
 
 
 
 220 
Eqn. 10 221 
where m1 ≤ m2 ≤ m3 ≤…≤ mn and x1, x2,…xn are the ratios of the amount of xi  in the mixture to 222 
the Pi value for that component, EffC is defined as the effective concentration, and we have 223 
termed Eqn.10 the Extended Lambert Pearson Model (ELPM). This model is a series of 224 
nested binomial expansions; if all the exponents are equivalent then this reduces to the 225 
simple additive model (Eqn.11).  226 
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Eqn. 11. The simple additive model (SAM),  where all the exponents of the components in a mixture 228 
are equal.  229 
Eqn. 11 can be rearranged to produce an expression known as the Sum of the Fractional 230 
Inhibitory Concentrations (FIC, see Appendix), which is equivalent to the LRM (Eqn. 1). For 231 
a binary system, with different concentration exponents, Eqn. 9 can also be shown to 232 
produce a format akin to the LRM; 233 
 234 
(
𝑥1
𝑋1
)
𝑚1
𝑚2
+
𝑥2
𝑋2
= 1 235 
Eqn. 12. The Extended Loewe Reference Model. 236 
We have termed this format of the LRM, the Extended LRM, as it represents an extension to 237 
the current model. 238 
 239 
2.2.4 Fitting procedures 240 
The LPM is an exponential decay function, and as such only approaches the ‘zero’ value at 241 
large concentrations. Lambert (2010) produced an extension to the basic model which 242 
allowed it to cut the concentration axis at the minimum inhibitory concentration (MIC). The 243 
function given for the effective concentration (Eqn. 8 of that publication) is only valid in the 244 
special cases where the concentration exponents are approximately 1.  To be able to use 245 
the new insights into combinations the following composite function was used; 246 
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else
EffCP
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EffC
else
PEffC
if
RTD
n
n
mn
 247 
Eqn. 13.The Extended Lambert-Pearson Model modified to allow the model to cross the concentration 248 
axis. RTD is the reciprocal of the time to detection, P0 is the RTD of the positive control.  249 
The MIC contour or surface is given by the expression 250 
𝐸𝑓𝑓𝐶 = 𝑒𝑥𝑝 (
1
𝑚𝑛
) 251 
Eqn. 14 252 
Model fitting was carried out using the non-linear fitting procedure of JMP (SAS Institute, 253 
Cary NC USA), or by Mathematica 8 (Wolfram Ill).  254 
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3 Results 255 
3.1 EFFECT OF NACL AND KCL ON TIME TO DETECTION 256 
The optical density/time curves for each of the organisms examined show similar patterns; a 257 
shift to the right of the OD/time curve with increasing salt concentration and a decrease in 258 
the maximum OD attained (results not shown). The parameters obtained from the analyses 259 
of the time to detection data and the fitting of the LPM are given in Table 1. Comparisons of 260 
the NaCl and KCl experiments for each organism are shown in Figures 1 to 3 for A. 261 
hydrophila, C. sakazakii and E.coli respectively; from the calculated MIC, the ratio of 262 
NaCl/KCl were 0.76, 0.77, and 0.77 respectively. This is in line with the ratio of the molecular 263 
weights of NaCl and KCl (0.784). The concentration exponents were found to range from 264 
1.51 to 2.72. 265 
3.2 MOCK EXPERIMENTS 266 
Mock combination experiments using a 20x20 well format were carried out using NaCl 267 
against A. hydrophila and C. sakazakii. The concentrations in the wells were added together 268 
and the TTD data analysed using the LPM (Eqn. 5). The fitted data resulted in a set of 269 
parameters similar to those previously found (compare parameters in Table 1 with Table 2). 270 
The data, as two independent inhibitors, were then analysed using the ELPM (Eqn. 10, n = 271 
2). The fitting of the ELPM to the separate concentration data resulted in an almost identical 272 
fit as the LPM, with statistically equivalent concentration exponents (Table 2).   273 
 Figure 4 plots the calculated effective concentration (using the parameters from the 274 
ELPM) for the mock experiment with C. sakazakii against the observed RTD data, along with 275 
the data modelled using the simple additive model (Eqn. 11). There is no evidence that the 276 
exponents are statistically distinct – as required by the hypothesis of the mock experiment. 277 
However, the values for P1 and P2 were statistically distinct (the 95% confidence intervals did 278 
not overlap) suggesting that small errors in the dilution sequences or other experimental 279 
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errors may be present. Contour plots (isoboles) of the observed C. sakazakii data and the 280 
modelled data are linear (figures not shown).  281 
 282 
3.3 COMBINED NACL AND KCL 283 
The format of the mock experiments was repeated but using KCl as the second 284 
antimicrobial. TTD data were fitted using both the SAM and the ELPM.  Table 3 gives the 285 
parameters obtained from the fittings of the ELPM. Parameters obtained were consistent 286 
with the individual parameters previously found (Table 1). For A. hydrophila and E. coli, the 287 
concentration exponents were statistically equivalent and hence the SAM and the ELPM 288 
fitted equally well, whereas for C. sakazakii the difference between the concentration 289 
exponents gave a slightly better fit with the ELPM. Figure 5 gives a stereo view of the 290 
observed and modelled data for the combined NaCl/KCl against C. sakazakii. Combining the 291 
total amount of moles of NaCl and KCl, a plot of the observed and fitted (ELPM) data is 292 
given in Figure 6. This essentially shows that the two humectants can be interchanged 293 
(compare Figure 6 with Figure 4) and that the effective concentration is an alternative 294 
scaling. The salt combinations used for C. sakazakii were not concentrated enough to give 295 
full inhibition, whereas for E. coli the MIC contour line can be seen in Figure 7, which gives a 296 
stereo view of the observed and fitted data; again plotting the isoboles gave linear lines 297 
(figure not shown). 298 
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4 Discussion 299 
A previous modelling study of preservatives in foods, based on the Gamma hypothesis, 300 
produced a model with good fits to the observed data (Lambert and Bidlas 2007). By 301 
considering, however, a mock experiment with two components each with a concentration 302 
exponent of 2, it was shown that this published model was inconsistent, and incompatible 303 
with the observations of combined salts against the three organisms studied. A Gamma 304 
model which contained functions for NaCl, and KCl as in the Eqn. 8 would have resulted in a 305 
conclusion of synergy, which is contrary to the observation of additive effects (Boziaris et al. 306 
2007). Hence for combined antimicrobials the Bliss model and therefore the Gamma concept 307 
as stated (Eqn. 1) are inappropriate in these cases. 308 
 The second of the two main combination paradigms is the Loewe reference model, 309 
from which the sum of the fractional inhibitory concentrations (FIC) and the idea of the 310 
combination index flow (Chou 2006). The mock experiment with m = 2 is wholly compatible 311 
with the LRM, and therefore the LRM is a better basis for the construction of a model for 312 
combined antimicrobials than Bliss (which forms a subset of the LRM when all exponents 313 
are equal to 1). Our studies using NaCl in mock combination experiments are in agreement 314 
with the LRM; and the isobologram (not shown) described linear isoboles connecting 315 
equivalent levels of inhibition as expected.  316 
 The models used to analyse the effect of the antimicrobials (e.g. the Hill model or the 317 
LPM) are each monotonic with respect to concentration. If the dose response is not 318 
monotonic then these models are not valid in their current guise. When formulating a model 319 
to analyse combinations of inhibitors two pieces of information are required for each 320 
component – the concentration at the inflexion point of the dose response curve and a 321 
measure of the slope at that point. For the LPM these are the P and the m values; and for 322 
the Hill model the EC50 and h values.  A previous study (Lambert and Lambert 2003) had 323 
suggested an empirical model for a binary system (with three fitted exponents) and had 324 
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stated that the exponents could not be predicted from the individual data; this model was 325 
used to study combined NaCl and KCl (Bidlas and Lambert 2008).  Serendipitously, the 326 
model used, although empirical and over-parameterised gave good fits because the salts 327 
had almost identical dose responses, for a given organism, and so the resulting equation 328 
was essentially compatible with the LRM.   329 
 The mock experiments using NaCl and the combined NaCl and KCl experiments are 330 
particularly useful in the synergy modelling debate; both are known to have concentration 331 
exponents of approximately 2, and it is well known from the literature that NaCl and KCl act 332 
in a similar way and that one can be replaced partially by the other on a molar basis and 333 
achieve the same antimicrobial effect (Bidlas and Lambert 2008; Boziaris et al 2007; Cebrian 334 
et al 2014; Gimeno et al 1999). 335 
 The LRM is, however, only applicable if the components in the mixture have identical 336 
concentration exponents (see appendix for an explanation). This also leads to an interesting 337 
argument: linear isoboles are obtained from mock combination experiments therefore these 338 
must indicate additive behaviour since self cannot synergise with self, whereas curved 339 
isoboles do not occur with self against self therefore these isoboles cannot indicate additive 340 
behaviour. But the LRM is only applicable if the components in the mix have identical 341 
concentration exponents and in these cases can only give linear isoboles. Indeed, this is 342 
only guaranteed if the components in a mix are identical, and from Table 1 these values are 343 
themselves subject to a statistical range. Thus it can be argued that linear isoboles can only 344 
occur when components in a mix have the same concentration exponents and only then 345 
does Berenbaum’s labelling of synergy, antagonism and additivity apply. If the components 346 
have (statistically) different concentration exponents then the LRM is not a valid reference 347 
model and Berenbaum’s labels are void. Interestingly, Loewe (1953) stated that when 348 
compounds with different dose responses were mixed he did not believe that the LRM was 349 
applicable. 350 
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 The ELPM can be shown to default to the LRM when all components have equivalent 351 
concentration exponents, and the LRM defaults to Bliss addition when these are equal to 1. 352 
Figures 4 to 7 show that the model and observed data agree and that NaCl and KCl are 353 
molar replacements for each other (Fig. 6). For a system to act additively (in the sense of 354 
acting independently) there can be no more than 2n parameters (where n = the number of 355 
components). We suggest that if the results of a mixed system can be evaluated or can be 356 
predicted on the basis of the individual parameters then that system cannot be synergistic.  357 
 For a binary system the ELPM can be shown to produce a format akin to the LRM, but 358 
one which preserves the concentration exponent information from each component. This 359 
equation has a significant prediction – that if components in the mix act independently and 360 
have different concentration exponents, then these will produce concave isoboles. A 361 
concave isobole is currently considered to be proof of a synergy between components in the 362 
mix.  Synergy, however, is a phenomenon that gives more than the expected ‘additive’ 363 
effect. Any model of synergy would require additional parameters to describe the interaction 364 
between the actives - in addition to the activities of the components themselves. If all 365 
components in a mix have identical concentration exponents then any departure from a 366 
linear isobole or (n-1) hyperplane is indicative of either synergy or antagonism. If any of the 367 
components has a statistically different concentration exponent then a curved isobole, or 368 
hypersurface for a given effect, is expected; deviation from this indicates synergy or 369 
antagonism i.e. the ELPM will not fit the data or will give parameters far from the predicted 370 
values (those of the individual adducts). Essentially the ELPM has generalised the reference 371 
model previously used and suggests that curved isoboles may no longer indicate synergy.  372 
 This new insight has impacts both in predictive modelling in foods and also modelling 373 
combinations in pharmaceutics. Leistner (2000) had encouraged food microbiologists to 374 
study the pharmaceutical literature for combined systems, but this study shows that the LRM 375 
(Eqn.4) and the SAM (Eqn. 11) are rearrangements of each other; the Chou-Talalay CI 376 
method uses the LRM format but does not consider the effect of disparate concentration 377 
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exponents. The rearrangement of the LRM in such cases results in multiple solutions, which 378 
invalidates the CI methodology used in pharmaceutical drug discovery. The new insight does 379 
not invalidate the Gamma approach used in food microbiology, however, because it has 380 
simply shown an error in the assumed function for combined antimicrobials (Eqn.2). The 381 
ELPM can be used to give the overall Gamma factor for the contribution of all the 382 
antimicrobials – if they act independently. The Gamma hypothesis (e.g., Eqn.1) is, by its very 383 
nature, an approximation, and introducing the ELPM (or similar functions) will refine that 384 
approximation. The ELPM is also a proposed solution to mixed exponents, but further work 385 
is needed to validate or refute this model.   386 
  387 
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Tables 488 
 489 
Table 1. Lambert-Pearson Model: Fitted parameters 490 
 A. hydrophila C. sakazakii E. coli 
Parameter NaCl KCl NaCl KCl NaCl KCl 
MIC (%) 
3.997 5.24 7.16 9.349 7.624 9.885 
(3.843-4.162) (5.111-5.377) (7.199-7.126) (9.140-9.565) (7.482-7.772) (9.679-10.100) 
P0(/h) 
0.2 0.204 0.225 0.217 0.156 0.152 
(0.196-0.204) (0.202-0.207) (0.223-0.227) (0.214-0.218) (0.154-0.157) (0.150-0.153) 
P(%) 
2.698 3.496 3.691 5.171 5.281 6.26 
(2.657-2.739) (3.462-3.529) (3.659-3.723) (5.126-5.216) (5.241-5.321) (6.211-6.309) 
m 
2.545 2.47 1.509 1.688 2.723 2.189 
(2.390-2.710) (2.375-2.568) (1.478-1.540) (1.649-1.729) (2.640-2.809) (2.126-2.254) 
RMSE/df 0.0072/86 0.0053/115 0.0032/147 0.0044/197 0.0040/187 0.0034/146 
 RMSE: root mean square error of fit; df: degrees of freedom; 95% Asymptotic confidence intervals given in brackets 491 
;concentrations are %(wt/vol) 492 
 493 
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Table 2. Fitted parameters for the NaCl/NaCl mock experiments.  494 
 A. hydrophila C. sakazakii 
Parameter NaCl (total) NaCl (Mock) NaCl (total) NaCl(Mock) 
MIC1 (%) 
3.717 
(3.566-3.871) 
3.547 
(3.386-3.723) 
6.872 
(6.771-6.975) 
6.786 
(6.616-6.964) 
MIC2(%) - 
3.804 
(3.583-4.050) 
- 
7.010 
(6.850-7.176) 
P0 (/h) 
0.263 
(0.255-0.271) 
0.262 
(0.254-0.270) 
0.223 
(0.221-0.225) 
0.223 
(0.221-0.225) 
P1 (%) 
2.565 
(2.523-2.605) 
2.474 
(2.420-2.529) 
3.868 
(3.846-3.889) 
3.806 
(3.762-3.851) 
P2(%) - 
2.623 
(2.534-2.716) 
- 
3.954 
(3.907-4.003) 
m1 
2.696 
(2.526-2.889) 
2.778 
(2.587-2.980) 
1.740 
(1.712-1.758) 
1.729 
(1.688-1.772) 
m2 - 
2.689 
(2.502-2.889) 
- 
1.746 
(1.713-1.781) 
RMSE/df 0.0123/207 0.0117/205 0.0032/395 0.0031/393 
NaCl (total) data fitted by the LPM; NaCl (Mock) data fitted by the ELPM. RMSE: root mean 495 
square error of fit; df: degrees of freedom; 95% Asymptotic confidence intervals given in 496 
brackets; concentrations are %(wt/vol) 497 
 498 
 499 
 500 
 501 
 502 
Table 3. ELPM fitted parameters for the NaCl/KCl combined experiments. 503 
Parameter A. hydrophila C. sakazakii E.coli 
MIC NaCl (%) 4.082(3.945-4.229) 7.381(7.206-7.565) 7.841(7.636-8.052) 
MIC KCl(%) 5.363(5.135-5.611) 9.980(9.741-10.228) 9.600(9.359-9.845) 
P0 (/h) 0.191(0.188-0.194) 0.193(0.192-0.194) 0.166(0.164-0.1680) 
P1, NaCl (%) 2.784(2.741-2.827) 4.020(3.977-4.065) 5.096(5.028-5.164) 
P2, KCl(%) 3.569(3.484-3.659) 5.233(5.175-5.292) 6.388(6.316-6.460) 
m1, NaCl 2.612(2.483-2.747) 1.646(1.610-1.682) 2.321(2.251-2.393) 
m2, KCl 2.456(2.338-2.578) 1.549(1.518-1.581) 2.457(2.374-2.542) 
RMSE/df 0.00648/273 0.00235/373 0.003245/195 
RMSE:root mean square error of fit; df: degrees of freedom; 95% Asymptotic confidence 504 
intervals given in brackets; concentrations are %(wt/vol) 505 
 506 
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Legends to figures 508 
 509 
Figure 1. A. hydrophila: effect of added salt (%wt/vol) on the fractional inhibition at 30oC in 510 
TSB. Observed data (NaCl, ;  KCl ) and the fitted LPM models (dashed and solid lines).  511 
 512 
Figure 2. C. sakazakii: effect of added salt (%wt/vol) on the fractional inhibition at 30oC in 513 
TSB. Observed data (NaCl,   ;  KCl ) and the fitted LPM models (dashed and solid lines).  514 
 515 
Figure 3. E. coli: effect of added salt (%wt/vol) on the fractional inhibition at 30oC in TSB. 516 
Observed data (NaCl,  ;  KCl ) and the fitted LPM models (dashed and solid lines).  517 
 518 
Figure 4. C. sakazakii: NaCl/NaCl mock experiment; effective concentration (modelled by the 519 
ELPM ) against the observed RTD (symbols, n = 391) and fitted model (Simple additive 520 
model, solid line). 521 
 522 
Figure 5. Stereo view of the combined NaCl/KCl (%wt/vol) effect on C. sakazakii; observed 523 
data (symbols) and the modelled data (grid). 524 
 525 
Figure 6. Effect of combined NaCl and KCl (as total mol/l) on C. sakazakii (n = 378). 526 
Observed –symbols and fitted model (ELPM) solid line. 527 
 528 
Figure 7: E. coli; stereo view of the NaCl/KCl (%wt/vol) combinations on the observed 529 
(symbols) and modelled (grid) RTD. 530 
 531 
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 533 
Appendix 1 534 
FAILURE OF LOEWE REFERENCE MODEL 535 
The Lambert-Pearson inhibition model can be expressed as 536 
𝑒𝑓𝑓 = 𝑒𝑥𝑝 {−(
𝑋
𝑃1
)
𝑚1
} 537 
Rearranging gives 538 
𝑃1 (𝑙𝑛 (
1
𝑒𝑓𝑓
))
1
𝑚1⁄
= 𝑋 539 
For a given effect (Eff) this gives the concentration, Xi for the given parameters Pi, and mi 540 
for each individual compound in the mixture. 541 
 542 
For a two component mixture, the LRM is given as 543 
𝑥1
𝑋1
+
𝑥2
𝑋2
= 1 544 
Substituting for Xi 545 
𝑥1
𝑃1 (𝑙𝑛 (
1
𝑒𝑓𝑓))
1
𝑚1⁄
+
𝑥2
𝑃2 (𝑙𝑛 (
1
𝑒𝑓𝑓))
1
𝑚2⁄
= 1 546 
 547 
This is the general model used in the Chou-Talalay method to obtain the combination 548 
index values.  549 
 550 
Case 1; m1 = m2 551 
1 =
𝑥1
𝑃1 (𝑙𝑛 (
1
𝑒𝑓𝑓))
1
𝑚1⁄
+
𝑥2
𝑃2 (𝑙𝑛 (
1
𝑒𝑓𝑓))
1
𝑚1⁄
 552 
 553 
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≡   (𝑙𝑛 (
1
𝑒𝑓𝑓
))
1
𝑚1⁄
=
𝑥1
𝑃1
+
𝑥2
𝑃2
 554 
 555 
≡    𝑙𝑛 (
1
𝑒𝑓𝑓
) = (
𝑥1
𝑃1
+
𝑥2
𝑃2
)
𝑚1
 556 
≡   (
1
𝑒𝑓𝑓
) = 𝑒𝑥𝑝 (
𝑥1
𝑃1
+
𝑥2
𝑃2
)
𝑚1
 557 
 558 
Hence, this leads to the simple additive model 559 
𝑒𝑓𝑓 = 𝑒𝑥𝑝 [− (
𝑥1
𝑃1
+
𝑥2
𝑃2
)
𝑚1
] 560 
 561 
 562 
Case 2; m1 ≠ m2 563 
1 =
𝑥1
𝑃1 (𝑙𝑛 (
1
𝑒𝑓𝑓))
1
𝑚1⁄
+
𝑥2
𝑃2 (𝑙𝑛 (
1
𝑒𝑓𝑓))
1
𝑚2⁄
 564 
(i) Multiplying through with (𝑙𝑛 (
1
𝑒𝑓𝑓
))
1
𝑚1⁄
gives 565 
(𝑙𝑛 (
1
𝑒𝑓𝑓
))
1
𝑚1⁄
=
𝑥1
𝑃1
+
𝑥2 (𝑙𝑛 (
1
𝑒𝑓𝑓))
1
𝑚1⁄
𝑃2 (𝑙𝑛 (
1
𝑒𝑓𝑓))
1
𝑚2⁄
 566 
 567 
≡ (𝑙𝑛 (
1
𝑒𝑓𝑓
))
1
𝑚1⁄
=
𝑥1
𝑃1
+
𝑥2
𝑃2
(𝑙𝑛 (
1
𝑒𝑓𝑓
))
1
𝑚1⁄ −
1
𝑚2⁄
 568 
𝑒𝑓𝑓 = 𝑒𝑥𝑝 [−(
𝑥1
𝑃1
+
𝑥2
𝑃2
(𝑙𝑛 (
1
𝑒𝑓𝑓
))
1
𝑚1⁄ −
1
𝑚2⁄
)
𝑚1
] 569 
 Page 28 
(ii) Multiplying through with (𝑙𝑛 (
1
𝑒𝑓𝑓
))
1
𝑚2⁄
leads to  570 
𝑒𝑓𝑓 = 𝑒𝑥𝑝 [−(
𝑥1
𝑃1
(𝑙𝑛 (
1
𝑒𝑓𝑓
))
1
𝑚2⁄ −
1
𝑚1⁄
+
𝑥2
𝑃2
)
𝑚2
] 571 
The expressions (i) and (ii) are only equivalent if m1 = m2. Consider the case where P1 = 572 
P2, but m1 = 1 and m2 = 2. This leads to a situation where there are two solutions to the 573 
LRM; hence the LRM is an invalid model in situations where the concentration exponents 574 
are not equivalent. 575 
 576 
 577 
